Efficacy and safety of dolutegravir plus lamivudine as a first-line regimen in clinical practice. Ciccullo A, Baldin G, Dusina A, Cossu MV, et al. AIDS Res Hum Retroviruses 2021 Feb 15. doi: 10.1089/AID.2020.0276.

Read + Share

Amedeo Smart

Independent Medical Education

Ciccullo A, Baldin G, Dusina A, Cossu MV, et al. Efficacy and safety of dolutegravir plus lamivudine as a first-line regimen in clinical practice. AIDS Res Hum Retroviruses 2021 Feb 15. doi: 10.1089/AID.2020.0276.
PMID: 33587008